FDA approves vaccine for meningococcal disease

On Oct. 29, the U.S. Food and Drug Administration (FDA) approved Trumenba, the first vaccine licensed in the United States to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroup B in individuals 10 through 25 years of age. Read more.

LEAVE A REPLY

Please enter your comment!
Please enter your name here